{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:30:08Z","timestamp":1792517408877,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jaad.2007.09.016","type":"journal-article","created":{"date-parts":[[2007,11,17]],"date-time":"2007-11-17T07:11:43Z","timestamp":1195283503000},"page":"S136-S142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"S","title":["Management of herpes zoster and postherpetic neuralgia"],"prefix":"10.1016","volume":"57","author":[{"given":"Stephen K.","family":"Tyring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.09.016_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","article-title":"Acute pain in herpes zoster and its impact on health-related quality of life","volume":"39","author":"Katz","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.09.016_bib2","first-page":"2437","article-title":"Management of herpes zoster (shingles) and postherpetic neuralgia","volume":"61","author":"Stankus","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2007.09.016_bib3","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archinte.1997.00440320117011","article-title":"Risk factors for postherpetic neuralgia","volume":"157","author":"Choo","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice: herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib5","first-page":"255","article-title":"Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?","volume":"49","author":"Alper","year":"2000","journal-title":"J Fam Pract"},{"key":"10.1016\/j.jaad.2007.09.016_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1468-3083.2000.00020.x","article-title":"Factors influencing pain outcome in herpes zoster: an observational study with valacyclovir","volume":"14","author":"Decroix","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2007.09.016_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archfami.9.9.863","article-title":"Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older","volume":"9","author":"Tyring","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/22.2.341","article-title":"Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials","volume":"22","author":"Wood","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.09.016_bib9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM199607043350107","article-title":"Postherpetic neuralgia\u2013pathogenesis, treatment, and prevention","volume":"335","author":"Kost","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1128\/AAC.39.7.1546","article-title":"Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults","volume":"39","author":"Beutner","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2007.09.016_bib11","first-page":"75","article-title":"Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster","volume":"37","author":"Shen","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jaad.2007.09.016_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1386-6532(03)00164-1","article-title":"Once, twice, or three times daily famciclovir compared with acyclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial","volume":"29","author":"Shafran","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaad.2007.09.016_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-123-2-199507150-00002","article-title":"Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial","volume":"123","author":"Tyring","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib14","unstructured":"Brentjens MH, Torres G, He J. Reduction of postherpetic neuralgia in herpes zoster: a study of the effects of gabapentin with valacyclovir during acute zoster outbreaks. Presented at: American Academy of Dermatology Annual Meeting; March 21-26, 2003; San Francisco, CA. Poster P38."},{"key":"10.1016\/j.jaad.2007.09.016_bib15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0161-6420(86)33678-9","article-title":"Oral acyclovir in the treatment of acute herpes zoster ophthalmicus","volume":"93","author":"Cobo","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2007.09.016_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/bjo.85.5.576","article-title":"Famciclovir for ophthalmic zoster: a randomized acyclovir controlled study","volume":"85","author":"Tyring","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaad.2007.09.016_bib17","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0161-6420(00)00222-0","article-title":"Comparison of the efficacy and safety of valacyclovir and acyclovir for the treatment of herpes zoster ophthalmicus","volume":"107","author":"Colin","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jaad.2007.09.016_bib18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198306163082404","article-title":"Acyclovir halts progression of herpes zoster in immunocompromised patients","volume":"308","author":"Balfour","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1081\/CNV-100000070","article-title":"A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients","volume":"19","author":"Tyring","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jaad.2007.09.016_bib20","unstructured":"Brentjens MH, Torres G, He J. A double-blind randomized study of the use of 2 grams vs 1 gram of valacyclovir TID for 7 days in the treatment of acute herpes zoster in immunocompromised patients. Presented at: American Academy of Dermatology Annual Meeting; March 21-26, 2003; San Francisco, CA. Poster P455."},{"key":"10.1016\/j.jaad.2007.09.016_bib21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199403313301304","article-title":"A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster","volume":"330","author":"Wood","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-125-5-199609010-00004","article-title":"Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial","volume":"125","author":"Whitley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(87)92331-2","article-title":"Prednisolone does not prevent post-herpetic neuralgia","volume":"2","author":"Esmann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2007.09.016_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1086\/368196","article-title":"Treatment and prevention of postherpetic neuralgia","volume":"36","author":"Dworkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2007.09.016_bib25","series-title":"Neurontin","year":"2005"},{"key":"10.1016\/j.jaad.2007.09.016_bib26","series-title":"Lidoderm","year":"2006"},{"key":"10.1016\/j.jaad.2007.09.016_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJM200011233432110","article-title":"A new treatment for postherpetic neuralgia","volume":"343","author":"Watson","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.09.016_bib28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2007.09.016_bib29","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2007.09.016_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jaad.2007.09.016_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3959(95)00146-8","article-title":"Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia","volume":"65","author":"Rowbotham","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.jaad.2007.09.016_bib32","first-page":"510","article-title":"A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia","volume":"15","author":"Watson","year":"1993","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2007.09.016_bib33","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2007.09.016_bib34","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2007.09.016_bib35","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2007.09.016_bib36","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207014405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207014405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:07:17Z","timestamp":1759270037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207014405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0190962207014405"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.09.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of herpes zoster and postherpetic neuralgia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}